PRKDC and breast carcinoma: The use of another DNA-PK inhibitor (NU7441) in MCF7 breast cancer cells did not modulate the p21CIP1/WAF1 or MDM2 protein levels at 24 h after IR, which is consistent with the unchanged pattern for most of our genes [38].